Analysis of US insurance data shows no link between return-to-school policies and antibiotic use for conjunctivitis, details on measles cases, COVID-19 impacts on fertility, and benefits of Paxlovid for stroke risk reduction.

April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.

April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.

Dr. Elliott discusses the impact of tariffs on prescription drug prices and answers listener questions on healthcare.

Learn about Medicare's coverage of Wegovy for weight loss and cardiovascular risk.